Hikaka Joanna, Hughes Carmel, Jones Rhys, Amende Hunter, Connolly Martin J, Martini Nataly
School of Pharmacy, University of Auckland, New Zealand.
Waitematā District Health Board, Auckland, New Zealand.
Explor Res Clin Soc Pharm. 2021 May 3;2:100018. doi: 10.1016/j.rcsop.2021.100018. eCollection 2021 Jun.
Pharmacist-facilitated medicines review services have been postulated as a way to address current inequities in health outcomes between Māori and non-Māori. These interventions have been shown internationally to improve the appropriate use of medicines but remain underutilised in Aotearoa New Zealand (NZ). By reviewing the literature and engaging with key stakeholders, we developed an intervention, which included collaborative goal-setting, education and medicines optimisation, for testing in a feasibility study.
To determine the feasibility (recruitment, intervention delivery, and data collection methods) of a pharmacist-facilitated medicines review intervention for Māori older adults, and proposed intervention outcomes.
This study was reported in accordance with the CONSORT 2010 statement: extension to randomised controlled pilot and feasibility trials and the Consolidated criteria for strengthening reporting of health research involving indigenous peoples: the CONSIDER statement. Participant eligibility criteria were: Māori; aged 55-plus; community-dwelling; enrolled in a general practice in Waitematā District Health Board (Auckland, NZ). Consented participants engaged in a medicines education component (participant and pharmacist) and an optional medicines optimisation component (participant, pharmacist and prescriber). Outcomes measures included: the feasibility of data collection tools and methods, time taken to conduct the intervention and research processes; medicines knowledge, medicines appropriateness and quality of life (QoL); pharmacist recommendations and prescriber acceptance rate.
Seventeen consented participants took part in the intervention from December 2019-March 2020 with the majority ( = 12) recruited through general practice mail-outs. Data collection was feasible using the predetermined outcome measure tools and was complete for all patient participants. Pharmacist intervention delivery was feasible. A mean of 9.5 recommendations were made per participant with a prescriber acceptance rate of 95%. These included non-medicine-related recommendations.
The feasibility testing of pharmacist-facilitated medicines review intervention developed for (and with) community-dwelling Māori older adults allows for intervention refinement and can be utilised for further studies relating to pharmacist services in primary care.
药剂师协助的药物审查服务被认为是解决当前毛利人和非毛利人在健康结果方面不平等问题的一种方式。这些干预措施在国际上已被证明能改善药物的合理使用，但在新西兰仍未得到充分利用。通过回顾文献并与关键利益相关者合作，我们开发了一种干预措施，包括协作目标设定、教育和药物优化，用于在一项可行性研究中进行测试。
确定药剂师协助的针对毛利老年人的药物审查干预措施的可行性（招募、干预实施和数据收集方法）以及提议干预的结果。
本研究按照CONSORT 2010声明进行报告：随机对照试验扩展到试点和可行性试验以及加强涉及土著人民的健康研究报告的综合标准：CONSIDER声明。参与者资格标准为：毛利人；55岁及以上；居住在社区；在怀塔玛塔地区卫生局（新西兰奥克兰）的普通诊所登记。同意参与的参与者参与了药物教育部分（参与者和药剂师）和一个可选的药物优化部分（参与者、药剂师和开处方者）。结果测量包括：数据收集工具和方法的可行性、进行干预和研究过程所需的时间；药物知识、药物合理性和生活质量（QoL）；药剂师的建议和开处方者的接受率。
2019年12月至2020年3月期间，17名同意参与的参与者参加了干预，其中大多数（=12）是通过普通诊所邮寄招募的。使用预定的结果测量工具进行数据收集是可行的，并且所有患者参与者的数据收集都已完成。药剂师的干预实施是可行的。每位参与者平均提出9.5条建议，开处方者的接受率为95%。这些建议包括与药物无关的建议。
为居住在社区的毛利老年人开发并与之合作开展的药剂师协助的药物审查干预措施的可行性测试，有助于对干预措施进行完善，并可用于与初级保健中药剂师服务相关的进一步研究。
Zotero 插件